H1N1 disseminated infection in a 3-month-old boy by Moniz, M et al.
BMJ Case Reports 2010; doi:10.1136/bcr.06.2010.3090 1 of 3
BACKGROUND
Earlier this year, a new infl uenza virus emerged and posed 
new challenges to the medical community. In Portugal, the 
fi rst case was reported on the 4 May 2010. Up to the 1 
April 2010, 115 adults and 7 children under the age of 18 
years died in Portugal. Of all these children, only one did 
not have a relevant medical history.1
The clinical features of patients with H1N1 virus infec-
tion are generally similar to those reported during peak 
periods of seasonal infl uenza and past pandemics.2 We 
report a case of pandemic infl uenza A related disseminated 
infection with coagulopathy, enteropathy and encephalitis 
in an infant aged 3 months. This is a rare manifestation 
associated to H1N1.
CASE PRESENTATION
A 3-month-old boy was admitted to our paediatric intensive 
care unit with bloody diarrhoea and severe coagulopathy. 
He had been in good health until 1 week before admission 
when an upper respiratory airway infection started. He was 
seen by his family doctor and an acute otitis media was diag-
nosed. Four days before admission, he presented with sev-
eral episodes of watery diarrhoea that during the next few 
days became bloody and with mucus. He never had fever, 
vomits, loss of appetite or alteration in consciousness.
He was a healthy black boy, born at 38 weeks of ges-
tational age, exclusively breast fed, fully immunised with 
rotavirus and with a negative family history for diseases.
On initial examination he appeared acutely ill and was 
irritable. He was afebrile (35.7ºC), with a blood pressure of 
106/60 mm Hg, a heart rate of 157 bpm and a respiratory 
rate of 32 per min. Oxygen saturation measured by pulse 
oximetry was 98% on room air. His skin was pale, with-
out petechial lesions, with a prolonged perfusion time. 
The mucous membranes were dry and the anterior fonta-
nel was depressed. The abdominal examination revealed 
a palpable spleen and liver 3 cm below the costal margin. 
The remainder of the examination was normal.
After placing a peripheral line, he started bleeding from 
the venous puncture locations.
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Summary
Earlier this year a new infl uenza virus emerged. In children, the clinical manifestations of H1N1 infection are similar to those reported 
during periods of seasonal infl uenza. We report on a 3-month-old boy with an upper respiratory tract infection who presented enteropathy, 
coagulopathy and encephalitis related to H1N1. The infection was confi rmed in nasopharyngeal aspirate, stools and cerebrospinal fl uid by 
real-time PCR. Treatment with oseltamivir was started.
INVESTIGATIONS
The initial laboratory evaluation showed thrombocytosis 
and severe coagulopathy with prolonged prothrombin 
time (PT) and activated partial thromboplastin time (aPTT) 
(table 1). The blood gases, renal function and ionogram 
were normal. He was transferred to our paediatric inten-
sive care unit.
A chest radiograph showed an interstitial infi ltrate and 
the abdominal ultrasound was normal.
OUTCOME AND FOLLOW-UP
Normal saline fl uid boluses, plasma, cryoprecipitate and 
vitamin K were administered at admission with progres-
sive normalisation of coagulation parameters.
From the 2nd to the 11th day of admission he presented 
generalised oedema due to progressive hypoalbuminaemia 
and hypoproteinaemia. He had a minimum value of albu-
min of 1.2 g/dl and of total proteins of 3.2 g/dl. An amino 
acid based hypoallergenic infant formula was started.
On day 4, due to persistent irritability a lumbar tap 
was performed and the cerebrospinal fl uid (CSF) revealed 
a total 25 cells/mm3 with polymorphonuclear predomi-
nance, a protein level of 65.9 mg/dl and a glucose con-
centration of 82 mg/dl. Ceftriaxone (100 mg/kg/day) was 
prescribed.
Real time reverse-transcriptase PCR (CLART FluAvir Kit; 
Genomica S.A.U, Madrid, Spain) for H1N1 in nasopha-
ryngeal, stool specimens and CSF were positive. Direct 
immunofl uorescence for infl uenza A and B, adenovirus 
and syncytial respiratory virus in nasopharyngeal secre-
tions were negative.
Specimens of blood were cultured and were sterile. The 
stool examination was negative for rotavirus and bacteria. 
The cultural examination and the PCR in CSF for adeno-
virus, enterovirus, cytomegalovirus and Epstein–Barr were 
negative. Serology for cytomegalovirus and Epstein–Barr 
was negative.
Oseltamivir (2 mg/kg, twice daily) was started on the 
4th day of admission and prescribed for 5 days and ceftri-
axone was stopped.
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Although he was clinically stable, he developed a pro-
gressive acute haemolytic anaemia with a haemoglobin 
value of 6.8 g/dl. The direct Coombs test was negative and 
the peripheral blood smear showed rare schizocytes, tar-
get cells and anisocytosis. He also had thrombocytopenia, 
discrete elevation of PT and aPTT with normal fi brinogen 
values. Transfusion of erythrocytes and platelets were nec-
essary (table 1).
Due to the alterations in the central nervous system 
previous reported, an Upshaw-Schulman syndrome was 
suspected. The measurement of a disintegrin and metal-
loproteinase with a thrombospondin type 1 motif member 
13 activity (ADAMST 13), the enzyme responsible for the 
degradation of the large multimers of Von-Willebrand fac-
tor, was normal.
The coagulation study revealed a decreased factor VII, 
antithrombin III and functional C protein. At discharge all 
these factors were rising. The complement activity was 
always unchanged.
The immunoglobulins and lymphocytic populations 
were studied and did not show alterations.
He was discharged with normal stools and blood analy-
ses (table 1). After 1 month of follow-up all his blood tests 
had normalised and he had an appropriate psycho-motor 
development.
DISCUSSION
This case describes a severe and disseminated disease asso-
ciated with the novel infl uenza A, swine-type H1N1 with 
involvement of the respiratory, gastrointestinal, haemato-
logical and central nervous system.
In children, seasonal infl uenza manifestations vary 
according to age, immunity status, medical conditions 
and previous contact with the virus. Among healthy chil-
dren generally is an acute, self-limited and uncomplicated 
disease.3 The classical manifestations of an upper respira-
tory tract infection are rare in infants under 2 years old in 
whom high grade fever, ill appearance and gastrointestinal 
symptoms are more likely to be present.
Acute otitis media and pneumonia are the most com-
mon complications associated to infl uenza.4 Neurological 
complications like encephalitis, encephalopathy and asep-
tic meningitis have been described.4 5 Morishima et al6 
reported 148 cases of encephalitis and encephalopathy 
associated with an infl uenza epidemic in Japan. In this 
study, 81.8% of the patients were under 5 years of age and 
the major clinical signs were loss of consciousness, convul-
sions, cough and vomiting.
According to the Centers for Disease Control and 
Prevention, people younger than 25 years of age are the 
most affected by this pandemic.7 In the paediatric popula-
tion, those with less than 12 months have the highest rates 
of hospital admissions and approximately 60% of children 
admitted to hospital have underlying medical conditions.8
Viral pneumonia, acute respiratory distress syndrome, 
secondary bacterial infection and exacerbation of airfl ow 
limitation have been reported as complications associated 
with swine infl uenza.8
Neurological disease caused by H1N1 was fi rst notifi ed 
on May 2009 in the USA.9 Four children with infl uenza-
like illness presented with seizures or altered mental status. 
The viral RNA was detected in nasopharyngeal specimens 
but not in the CSF.9
Although, in literature, there are some questions about 
the possibility that infl uenza virus do not directly invade 
the central nervous system, a few reports have obtained a 
positive PCR result in CSF for infl uenza type A.10 This was 
the technique used by our laboratory to identify H1N1 in 
our patient.
With this case, the authors describe a very rare and 
severe presentation associated to this new infl uenza virus. 
Our patient had a disseminated infection with respiratory, 
gastrointestinal and neurological involvement and with a 
sepsis-like illness with an intravascular coagulation disor-
der. This late fi nding was evidenced by the microangio-
pathic anaemia, thrombocytopenia and coagulopathy with 
low levels of factor VII, antithrombin III and functional C 
protein that he developed.
In face of these blood alterations and mental status 
changes, an Upshaw-Schulman syndrome was suspected 
even though his renal function was normal. This disease 
was ruled out after a normal study of ADAMST 13 activity.
The negative results of PCR for adenovirus and entero-
virus in CSF, of the ELISA for rotavirus and of viral serolo-
gies, blood and stool cultures, suggest that H1N1 was 
responsible for the haemorrhagic colitis, encephalitis and 
sepsis that the patient presented. The test used to diagnose 
H1N1 was named CLART FluAvir which has a 100% of 
sensitivity and specifi city with a negative and positive pre-
dictive value of 100%.11
In this case, time from onset of illness to initiation of 
antiviral treatment was 1 week. Most studies suggest that 
the use of oseltamivir is benefi cial in avoiding complica-
tions when started early in the course of the disease.6 The 
small age of our child adding to the late prescription of 
oseltamivir were probably the factors that have most con-
tributed to the severity of the clinical picture.
With this clinical report the authors want to draw 
attention to a serious and possible presentation of 
H1N1disease.
Table 1 Haematological analyses and C reactive protein (CRP) 
during the admission time
Days of presentation
 Admission Day 6 D12 D24
Haematocrit (%) 28.6 20.4 19.3 27
Haemoglobin (g/dl) 9.6 7.3 6.8 9.3
Mean corpuscular 
volume (fl )
73.7 69.2 75.1 77.1
White cells (per ul) 21800 16500 27200 10500
Neutrophils (%) 54.9 65.6 55.0 17.8
Lymphocytes (%) 31.0 30.2 30.1 65.9
Eosinophils (%) 0.6 0.5 0.1 7.3
Monocytes (%) 13.4 3.6 14.7 8.0
Basophiles (%) 0.1 0.1 0.1 1.0
Platelets 912000 53000 16000 474000
Prothrombin time (s) 143 14.6 13.3 10.1
Partial thromboplastin 
time (s)
75.3 39.3 32.1 31.5
d-Dimer (ug/l) 50 179.5 125 92.8
Fibrinogen (mg/dl) 100 396 349 379
CRP (mg/dl) 0.79 5.79 9.6 0.24
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Learning points
Pandemic H1N1 has similar clinical manifestations to  ▶
seasonal infl uenza.
Complications associated to H1N1 can be severe. ▶
Disseminated infection is a possible complication that  ▶
clinicians should be aware of. 
